Subependymal giant cell astrocytoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
No edit summary
Sujit Routray (talk | contribs)
Line 9: Line 9:
*The prevalence of subependymal giant cell astrocytoma is estimated to be 110 cases in total.<ref name="NabboutSantos1999">{{cite journal|last1=Nabbout|first1=R|last2=Santos|first2=M|last3=Rolland|first3=Y|last4=Delalande|first4=O|last5=Dulac|first5=O|last6=Chiron|first6=C|title=Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis|journal=Journal of Neurology, Neurosurgery & Psychiatry|volume=66|issue=3|year=1999|pages=370–375|issn=0022-3050|doi=10.1136/jnnp.66.3.370}}</ref>
*The prevalence of subependymal giant cell astrocytoma is estimated to be 110 cases in total.<ref name="NabboutSantos1999">{{cite journal|last1=Nabbout|first1=R|last2=Santos|first2=M|last3=Rolland|first3=Y|last4=Delalande|first4=O|last5=Dulac|first5=O|last6=Chiron|first6=C|title=Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis|journal=Journal of Neurology, Neurosurgery & Psychiatry|volume=66|issue=3|year=1999|pages=370–375|issn=0022-3050|doi=10.1136/jnnp.66.3.370}}</ref>
==Incidence==
==Incidence==
*The incidence of subependymal giant cell astrocytoma is approximately 2.5 per 100,000 individuals in the United States.


==Age==
==Age==

Revision as of 18:44, 4 November 2015

Subependymal giant cell astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subependymal Giant Cell Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subependymal giant cell astrocytoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subependymal giant cell astrocytoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subependymal giant cell astrocytoma epidemiology and demographics

CDC on Subependymal giant cell astrocytoma epidemiology and demographics

Subependymal giant cell astrocytoma epidemiology and demographics in the news

Blogs on Subependymal giant cell astrocytoma epidemiology and demographics

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Subependymal giant cell astrocytoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Prevalence

  • There have been 110 reported cases of subependymal giant cell astrocytomas in the literature.[1]
  • The prevalence of subependymal giant cell astrocytoma is estimated to be 110 cases in total.[1]

Incidence

  • The incidence of subependymal giant cell astrocytoma is approximately 2.5 per 100,000 individuals in the United States.

Age

Gender

Race

Reference

  1. 1.0 1.1 Nabbout, R; Santos, M; Rolland, Y; Delalande, O; Dulac, O; Chiron, C (1999). "Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis". Journal of Neurology, Neurosurgery & Psychiatry. 66 (3): 370–375. doi:10.1136/jnnp.66.3.370. ISSN 0022-3050.


Template:WikiDoc Sources